Accumulating evidence shows that many human tumors, including the brain, cervical, and prostate cancers, exhibit elevated APE/Ref-1 expression and abnormal subcellular localization compared to normal tissues, making it an attractive druggable target for developing new cancer therapeutic strategies [12,17,18]. The gene discussed is APEX1; the disease is prostate carcinoma.